80 results
Page 2 of 4
424B5
n0voq6q7cl
16 Mar 22
Prospectus supplement for primary offering
8:00am
8-K
EX-10.1
kbv2jde
7 Feb 22
Axcella Therapeutics Announces Appointment of New Chief Financial Officer
4:00pm
8-K
EX-10.1
vq7bn7 3lh
7 Dec 21
Departure of Directors or Certain Officers
6:15am
8-K
EX-10.1
pfrjhlv
7 Sep 21
Entry into a Material Definitive Agreement
4:16pm
8-K
EX-10.1
uyxldknb
3 Mar 21
Axcella Announces Alison D. Schecter, M.D., as President of R&D
5:26pm
S-3
EX-1.2
5vpku
5 Jun 20
Shelf registration
5:02pm
S-3
EX-4.4
m5ltgk4temga
5 Jun 20
Shelf registration
5:02pm
S-3
xu5ked6wi5wkrwurx1
5 Jun 20
Shelf registration
5:02pm
S-3
EX-4.3
f13nurcvlp 153
5 Jun 20
Shelf registration
5:02pm
424B4
4weo9
14 May 20
Prospectus supplement with pricing info
5:15pm